• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宏基因组下一代测序在非结核分枝杆菌肺病中的临床应用的诊断性能。

Diagnostic performance of metagenomic next-generation sequencing in non-tuberculous mycobacterial pulmonary disease when applied to clinical practice.

机构信息

Shanghai Clinical Research Center for Infectious Disease (Tuberculosis), Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.

Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.

出版信息

Infection. 2023 Apr;51(2):397-405. doi: 10.1007/s15010-022-01890-z. Epub 2022 Aug 1.

DOI:10.1007/s15010-022-01890-z
PMID:35913608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10042946/
Abstract

OBJECTIVE

To compare non-tuberculous mycobacterial pulmonary disease (NTMPD) diagnosis by metagenomic next-generation sequencing (mNGS) with Bactec mycobacterial growth indicator tube (MGIT) 960.

METHODS

A total of 422 patients with suspected NTMPD in Shanghai Pulmonary Hospital between January 2020 and May 2021 were retrospectively analyzed; 194 were diagnosed with NTMPD. The diagnostic performance of mNGS and MGIT 960 for NTMPD was assessed. Receiver operating characteristic (ROC) curves and areas under curve (AUCs) were compared.

RESULTS

The sensitivity of mNGS in NTMPD diagnosis was 81.4% and higher than that of MGIT 960 (53.6%). The specificity of mNGS in NTMPD diagnosis was 97.8%, similar to that of MGIT 960 (100%). The sensitivity of combined mNGS and MGIT 960 in NTMPD diagnosis was 91.8%. The sensitivity of mNGS for bronchoalveolar lavage fluid (BALF), pulmonary puncture tissue fluid, and sputum was 84.8%, 80.6%, and 77.5%, respectively; all were higher than that of MGIT 960 (P < 0.05). The AUC of mNGS and MGIT 960 was 0.897 and 0.768, respectively. The AUC of mNGS were BALF (0.916), pulmonary puncture tissue fluid (0.903), and sputum (0.870).

CONCLUSION

The sensitivity of mNGS was superior to that of Bactec MGIT 960; the specificity in NTMPD diagnosis was similar. mNGS shows effective performance in NTMPD diagnosis.

摘要

目的

比较宏基因组下一代测序(mNGS)与 Bactec 分枝杆菌液体培养检测系统(MGIT)960 对非结核分枝杆菌肺病(NTMPD)的诊断价值。

方法

回顾性分析 2020 年 1 月至 2021 年 5 月上海肺科医院 422 例疑似 NTMPD 患者,194 例患者诊断为 NTMPD。评估 mNGS 和 MGIT 960 对 NTMPD 的诊断性能。比较受试者工作特征(ROC)曲线和曲线下面积(AUC)。

结果

mNGS 诊断 NTMPD 的敏感度为 81.4%,高于 MGIT 960(53.6%)。mNGS 诊断 NTMPD 的特异度为 97.8%,与 MGIT 960(100%)相当。mNGS 联合 MGIT 960 诊断 NTMPD 的敏感度为 91.8%。mNGS 对支气管肺泡灌洗液(BALF)、经皮肺穿刺组织液和痰液的敏感度分别为 84.8%、80.6%和 77.5%,均高于 MGIT 960(P < 0.05)。mNGS 和 MGIT 960 的 AUC 分别为 0.897 和 0.768。mNGS 的 BALF(0.916)、经皮肺穿刺组织液(0.903)和痰液(0.870)的 AUC 均大于 MGIT 960。

结论

mNGS 的敏感度优于 Bactec MGIT 960,对 NTMPD 的诊断特异性相当。mNGS 对 NTMPD 具有较好的诊断效能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff9c/10042946/8d94804d7107/15010_2022_1890_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff9c/10042946/7325b6d4f403/15010_2022_1890_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff9c/10042946/11ffbcaf0571/15010_2022_1890_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff9c/10042946/8d94804d7107/15010_2022_1890_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff9c/10042946/7325b6d4f403/15010_2022_1890_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff9c/10042946/11ffbcaf0571/15010_2022_1890_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff9c/10042946/8d94804d7107/15010_2022_1890_Fig3_HTML.jpg

相似文献

1
Diagnostic performance of metagenomic next-generation sequencing in non-tuberculous mycobacterial pulmonary disease when applied to clinical practice.宏基因组下一代测序在非结核分枝杆菌肺病中的临床应用的诊断性能。
Infection. 2023 Apr;51(2):397-405. doi: 10.1007/s15010-022-01890-z. Epub 2022 Aug 1.
2
Diagnosis of Non-Tuberculous Mycobacterial Pulmonary Disease by Metagenomic Next-Generation Sequencing on Bronchoalveolar Lavage Fluid.基于支气管肺泡灌洗液宏基因组二代测序技术诊断非结核分枝杆菌肺病
Infect Drug Resist. 2023 Jun 26;16:4137-4145. doi: 10.2147/IDR.S417088. eCollection 2023.
3
Cellular analysis and metagenomic next-generation sequencing of bronchoalveolar lavage fluid in the distinction between pulmonary non-infectious and infectious disease.对支气管肺泡灌洗液进行细胞分析和宏基因组下一代测序,以区分肺部的非传染性和传染性疾病。
Front Cell Infect Microbiol. 2023 Jan 25;12:1023978. doi: 10.3389/fcimb.2022.1023978. eCollection 2022.
4
Comparative diagnostic utility of metagenomic next-generation sequencing, GeneXpert, modified Ziehl-Neelsen staining, and culture using cerebrospinal fluid for tuberculous meningitis: A multi-center, retrospective study in China.基于宏基因组下一代测序、GeneXpert、改良抗酸染色和脑脊液培养的结核性脑膜炎比较诊断效能:中国多中心回顾性研究。
J Clin Lab Anal. 2022 Apr;36(4):e24307. doi: 10.1002/jcla.24307. Epub 2022 Feb 24.
5
Improving Suspected Pulmonary Infection Diagnosis by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing: a Multicenter Retrospective Study.通过支气管肺泡灌洗液宏基因组下一代测序提高疑似肺部感染诊断:一项多中心回顾性研究。
Microbiol Spectr. 2022 Aug 31;10(4):e0247321. doi: 10.1128/spectrum.02473-21. Epub 2022 Aug 9.
6
The value of metagenomic next-generation sequencing with different nucleic acid extracting methods of cell-free DNA or whole-cell DNA in the diagnosis of non-neutropenic pulmonary aspergillosis.不同核酸提取方法(细胞游离 DNA 或全细胞 DNA)的宏基因组二代测序在诊断非中性粒细胞减少性肺部曲霉病中的价值。
Front Cell Infect Microbiol. 2024 Jul 29;14:1398190. doi: 10.3389/fcimb.2024.1398190. eCollection 2024.
7
Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease.下一代宏基因组测序在抗酸染色痰涂片阴性肺结核和非结核分枝杆菌肺病中显示出卓越的诊断性能。
Front Microbiol. 2022 Jul 1;13:898195. doi: 10.3389/fmicb.2022.898195. eCollection 2022.
8
Diagnostic efficacy of metagenomic next generation sequencing in bronchoalveolar lavage fluid for proven invasive pulmonary aspergillosis.宏基因组下一代测序对支气管肺泡灌洗液中确诊侵袭性肺曲霉病的诊断效能。
Front Cell Infect Microbiol. 2023 Aug 24;13:1223576. doi: 10.3389/fcimb.2023.1223576. eCollection 2023.
9
The performance of detecting Mycobacterium tuberculosis complex in lung biopsy tissue by metagenomic next-generation sequencing.宏基因组下一代测序检测肺活检组织中结核分枝杆菌复合体的性能。
BMC Pulm Med. 2022 Jul 28;22(1):288. doi: 10.1186/s12890-022-02079-8.
10
Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients.mNGS 在非中性粒细胞减少症患者支气管肺泡灌洗液中用于诊断侵袭性肺曲霉病的性能。
Front Cell Infect Microbiol. 2023 Oct 31;13:1271853. doi: 10.3389/fcimb.2023.1271853. eCollection 2023.

引用本文的文献

1
Metagenomic sequencing for identification of nontuberculous mycobacteria and other pathogens in patients with mixed infection of the lung.宏基因组测序用于鉴定肺部混合感染患者中的非结核分枝杆菌及其他病原体。
Front Cell Infect Microbiol. 2025 Jun 19;15:1592216. doi: 10.3389/fcimb.2025.1592216. eCollection 2025.
2
Comparison of molecular testing methods for diagnosing non-tuberculous mycobacterial infections.用于诊断非结核分枝杆菌感染的分子检测方法比较
Eur J Clin Microbiol Infect Dis. 2025 Jan;44(1):109-116. doi: 10.1007/s10096-024-04981-x. Epub 2024 Nov 13.
3
Case report: -induced lymph node infection in a patient with chronic myeloproliferative neoplasm misdiagnosed as tuberculous lymphadenitis.

本文引用的文献

1
Factors Associated with Treatment Outcome in Patients with Nontuberculous Mycobacterial Pulmonary Disease: A Large Population-Based Retrospective Cohort Study in Shanghai.非结核分枝杆菌肺病患者治疗结果的相关因素:上海一项基于大人群的回顾性队列研究
Trop Med Infect Dis. 2022 Feb 15;7(2):27. doi: 10.3390/tropicalmed7020027.
2
Diagnostic Accuracy of Metagenomic Next-Generation Sequencing in Sputum-Scarce or Smear-Negative Cases with Suspected Pulmonary Tuberculosis.宏基因组下一代测序技术在疑似肺结核但痰液稀少或涂片阴性病例中的诊断准确性。
Biomed Res Int. 2021 Sep 3;2021:9970817. doi: 10.1155/2021/9970817. eCollection 2021.
3
病例报告:-诱导的慢性骨髓增殖性肿瘤患者的淋巴结感染,误诊为结核性淋巴结炎。
Front Public Health. 2024 Sep 24;12:1387722. doi: 10.3389/fpubh.2024.1387722. eCollection 2024.
4
Adjuvant surgical resection for nontuberculous mycobacterial pulmonary disease: Effectiveness and complications.非结核分枝杆菌肺病的辅助性手术切除:有效性及并发症
Ann Thorac Med. 2024 Apr-Jun;19(2):131-138. doi: 10.4103/atm.atm_237_23. Epub 2024 Apr 25.
5
Incorporating direct molecular diagnostics in management algorithms for nontuberculous mycobacteria: Is it high time?将直接分子诊断纳入非结核分枝杆菌管理算法:是时候了吗?
IJID Reg. 2023 Dec 13;10:140-145. doi: 10.1016/j.ijregi.2023.12.003. eCollection 2024 Mar.
6
Clinical application of amplification-based versus amplification-free metagenomic next-generation sequencing test in infectious diseases.基于扩增与无扩增的宏基因组下一代测序检测在感染性疾病中的临床应用。
Front Cell Infect Microbiol. 2023 Nov 29;13:1138174. doi: 10.3389/fcimb.2023.1138174. eCollection 2023.
7
Performance of the MeltPro TB assay as initial test for diagnosis of pulmonary tuberculosis with drug-resistance detection.MeltPro TB assay 在耐药性检测中作为初始检测用于诊断肺结核的性能。
Mol Med. 2023 Nov 7;29(1):153. doi: 10.1186/s10020-023-00743-1.
8
Diagnosis of Non-Tuberculous Mycobacterial Pulmonary Disease by Metagenomic Next-Generation Sequencing on Bronchoalveolar Lavage Fluid.基于支气管肺泡灌洗液宏基因组二代测序技术诊断非结核分枝杆菌肺病
Infect Drug Resist. 2023 Jun 26;16:4137-4145. doi: 10.2147/IDR.S417088. eCollection 2023.
9
Clinical Value of Metagenomic Next-Generation Sequencing Using Spinal Tissue in the Rapid Diagnosis of Spinal Tuberculosis.使用脊髓组织的宏基因组下一代测序在脊柱结核快速诊断中的临床价值
Infect Drug Resist. 2023 May 29;16:3305-3313. doi: 10.2147/IDR.S410914. eCollection 2023.
10
Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals.非转诊医院应用宏基因组下一代测序技术快速诊断非结核分枝杆菌肺病。
Front Cell Infect Microbiol. 2023 Jan 24;12:1083497. doi: 10.3389/fcimb.2022.1083497. eCollection 2022.
Clinical Application of Metagenomic Next-Generation Sequencing for Suspected Infections in Patients With Primary Immunodeficiency Disease.
宏基因组下一代测序在原发性免疫缺陷病疑似感染患者中的临床应用。
Front Immunol. 2021 Aug 13;12:696403. doi: 10.3389/fimmu.2021.696403. eCollection 2021.
4
Metagenomic Next-Generation Sequencing Can Clinch Diagnosis of Non-Tuberculous Mycobacterial Infections: A Case Report.宏基因组下一代测序可确诊非结核分枝杆菌感染:一例报告
Front Med (Lausanne). 2021 Jul 26;8:679755. doi: 10.3389/fmed.2021.679755. eCollection 2021.
5
Co-Infection Pneumonia with and in a Patient without HIV Infection Diagnosed by Metagenomic Next-Generation Sequencing.通过宏基因组下一代测序诊断的一名无HIV感染患者的合并感染性肺炎及[此处原文缺失两种病原体名称]感染
Infect Drug Resist. 2021 Mar 4;14:879-888. doi: 10.2147/IDR.S292768. eCollection 2021.
6
Tuberculosis Diagnosis by Metagenomic Next-generation Sequencing on Bronchoalveolar Lavage Fluid: a cross-sectional analysis.宏基因组下一代测序在支气管肺泡灌洗液中的结核分枝杆菌诊断:一项横断面分析。
Int J Infect Dis. 2021 Mar;104:50-57. doi: 10.1016/j.ijid.2020.12.063. Epub 2020 Dec 24.
7
Clinical metagenomic sequencing for diagnosis of pulmonary tuberculosis.临床宏基因组测序诊断肺结核。
J Infect. 2020 Oct;81(4):567-574. doi: 10.1016/j.jinf.2020.08.004. Epub 2020 Aug 5.
8
Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii.利福喷丁、替加环素和米诺环素新方案与标准方案治疗肺堪萨斯分枝杆菌的比较。
Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.00810-20.
9
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.非结核分枝杆菌肺病的治疗:美国胸科学会/欧洲呼吸学会/欧洲临床微生物学与感染病学会/美国感染病学会官方临床实践指南
Eur Respir J. 2020 Jul 7;56(1). doi: 10.1183/13993003.00535-2020. Print 2020 Jul.
10
Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.结核病和非结核分枝杆菌感染——流行病学、诊断和治疗的比较分析。
J Biomed Sci. 2020 Jun 17;27(1):74. doi: 10.1186/s12929-020-00667-6.